Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5cf811e10ad9068ddf72c04b69c8ba8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-92 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate |
1996-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b045d8276b725557f2b7403c48f747d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dbf3fcc9009999e4a3a65c73e5578d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23dc62133c6f2758534b510600e70d25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24969f6935fedf219a1c077a6bfd01d8 |
publicationDate |
1998-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5707866-A |
titleOfInvention |
DNA oligomers for inhibition of HIV by decreasing ribosomal frameshifting |
abstract |
The invention relates to the use of antisense DNA oligomers to decrease the occurrence of ribosomal frameshifting required for the production of HIV enzymatic proteins when translating HIV messenger RNA, which should interfere with the production of virions and disrupt HIV life cycle. The antisense DNA oligomers are complementary to regions of the RNA of the small ribosomal subunit of mammalian cells, which are involved in the control of translation fidelity. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006017522-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001032128-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7339051-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005100885-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011046200-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008102518-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291438-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007059684-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006017522-A2 |
priorityDate |
1994-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |